Accufuser Product Launch
LTR Medical has entered an exclusive distribution agreement with Woo Young Medical to distribute their new generation of elastomeric infusion technologies into the Australian market. Woo Young Medical are one of the global leaders in ambulatory infusion technology, based in Korea. Pictured here are Lee Rodne, CEO of LTR Medical and Brian Cha, COO/President of Woo Young Medical. The Accufuser range has several unique key technical features and clinical benefits that set it apart from the generic elastomeric pumps. It allows patients to receive their chemotherapy, antibiotics or pain medication either at home or in hospital, and to mobilise without being tied to an electronic infusion pump. The Accufuser range includes continuous flow pumps, selectable rate continuous flow pumps and PCA pumps with either a fixed or selectable basal rate. The range is available in 60ml, 100ml, 200ml, 300ml and 600ml. For more information, visit our product page or call [...]
MEDXL Training Day
The LTR Medical team enjoyed a training day with Gilles Asselin from MEDXL. Gilles joined us from Montreal, Canada. For more information on the MEDXL range please see our product page.
Safe Delivery of IV Push Medication with Springfusor
A recent webinar by the Institute for Safe Medical Practices (ISMP) titled “Designing Reliable Practices for IV Push Medication Use: A Focus on Safe Administration” found that giving IV medications too fast is the most common type of IV drug error, with a wide variety in rates of administration. Take the risk out of the equation by using the Springfusor to deliver IV push medications. For the webinar notes click here. For more information on the Springfusor visit the product page.
V-Set to maximise patient safety
The V-Set is a unique multi-lumen connector used to ensure the accuracy in the delivery of infusions and injections with no mixing of medications in the lines as they are independent from port to entry at cannula with no common space. This reduces the risk of drug interactions and adverse events, providing enhanced quality assurance and safety in the delivery of critical medications. In their article “Guidelines for the safe practice of total intravenous anaesthesia (TIVA), Nimmo et al recommend that during the delivery of TIVA, drug and fluid lines should join as close to the patient as possible to minimise dead space. Read the full article here. For more information visit our product page.
Springfusor for Subcutaneous Immunoglobulin (SCIg)
Immunoglobulin replacement therapy, first administered in the 1980's, has been the mainstay of treatment for primary and secondary immunodeficiencies. In the past, the most common treatment for immunoglobulin replacement was by intravenous infusion every 3-4 weeks. This is moving towards weekly subcutaneous immunoglobulin (SCIg) which can be self-administered by patients. The Springfusor is the ideal device to deliver SCIg, with the advantages including: No alarms No batteries No rate setting required Low pump cost Lightweight and portable Switching to self-administered SCIg has been shown to improve the quality of life and perceptions of general health in both adults and children, with improvements in pain and vitality and fewer days missed from school or work. For more information on the Springfusor visit our product page.
Danny and Gilles at SHPA
It was a pleasure to have Gilles Asselin from MedXL, Montreal, Canada visit us for the SHPA Medicines Management 2019 Conference on the Gold Coast this weekend, pictured here with Danny Zanardo, VP Commercial for LTR Medical